Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03263143 · ClinicalTrials.gov registry record · NA

Palliative Care in the ICU

A NA study, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
242
Enrollment target

NCT03263143: Completed NA study, sponsored by Washington University School of Medicine.

NCT03263143 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 242 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03263143, a NA study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
242 participants
Enrollment target

Study Summary

The study compares early palliative care consultation to standard of care in the medical intensive care unit (ICU). The study will assess if the intervention leads to an increased proportion of clearly delineated goals of care and examine if this intervention leads to decreased healthcare resource utilization such as length of stay, duration of intensive treatments including mechanical ventilation, and hospital re-admissions.

Primary Outcome

As determined by code status orders in the electronic medical record

Interventions

  • OTHER Palliative Care

Trial Details

FieldValue
Enrollment Target 242 participants
Start Date 2017-08-07
Est. Completion 2018-11-30
Phase NA

What the finished NCT03263143 record still lists

NCT03263143 is an interventional study that assigns participants to a tested intervention. The registered 242 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).

The record links to 0 conditions, and to 1 intervention - of which Palliative Care is the first listed.

NCT03263143 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03263143 about?

NCT03263143 is a clinical study titled "Palliative Care in the ICU". The study compares early palliative care consultation to standard of care in the medical intensive care unit (ICU). The study will assess if the intervention leads to an increased proportion of clearly delineated goals of care and examine if this intervention leads to decreased healthcare resource u...

What is the current status of trial NCT03263143?

This trial is currently completed. It is a NA study. The enrollment target is 242 participants. The study started on 2017-08-07. Estimated completion is 2018-11-30.

What interventions are being tested in trial NCT03263143?

The interventions under investigation include: Palliative Care (OTHER).

Who is sponsoring clinical trial NCT03263143?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03263143's enrollment target sits among peer trials

242 439th of 2000 higher than 1,561 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03556228 · 242 participants · Phase 1

    VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  • NCT04260022 · 242 participants · Phase 1

    Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

  • NCT04459000 · 242 participants · NA

    Substance Use Treatment and Access to Resources (STARS) Project

  • NCT05644496 · 242 participants · Phase 4

    ZYNRELEF for Pain Management in Total Knee Arthroplasty

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03263143, the US trial registry maintained by the National Library of Medicine. NCT03263143 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.